Urinary Proteolytic Activation of Renal Epithelial Na+ Channels in Chronic Heart Failure

Hypertension

Volumn 67, Issue 1, 2016, Pages 197-205

  Zheng, Hong ^a   Liu, Xuefei ^a   Sharma, Neeru M ^a   Li, Yulong ^b   Pliquett, Rainer U ^c   Patel, Kaushik P ^a  

^a NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

heart failure; Na+ and water retention; podocyte; protease; renal function

Indexed keywords

AMILORIDE; APROTININ; BENZAMIL; BRAIN NATRIURETIC PEPTIDE; CREATININE; DESMIN; EPITHELIAL SODIUM CHANNEL; FURIN; PLASMINOGEN; PODOCIN; PROSTASIN; SODIUM; SERINE PROTEINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DIASTOLIC DYSFUNCTION; ENZYME ACTIVITY; GLOMERULUS BASEMENT MEMBRANE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE CONTRACTILITY; HEART WEIGHT; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KIDNEY MASS; LUNG WEIGHT; MICTURITION; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; SODIUM EXCRETION; SODIUM RETENTION; TRANSMISSION ELECTRON MICROSCOPY; URINALYSIS; WHOLE CELL PATCH CLAMP; ZYMOGRAPHY; ANIMAL; CELL CULTURE; DISEASE MODEL; ENZYME ACTIVATION; HUMAN; KIDNEY COLLECTING TUBULE; METABOLISM; MOUSE; PATCH CLAMP TECHNIQUE; PATHOLOGY; URINE;

ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; EPITHELIAL SODIUM CHANNELS; HEART FAILURE; HUMANS; KIDNEY TUBULES, COLLECTING; MICE; PATCH-CLAMP TECHNIQUES; RATS; SERINE PROTEASES;

EID: 84951570238     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.115.05838     Document Type: Article

References (48)

1. Navas JP, Martinez-Maldonado M. Pathophysiology of edema in congestive heart failure. Heart Dis Stroke. 1993;2:325-329.
2. Rasool A, Palevsky PM. Treatment of edematous disorders with diuretics. Am J Med. Sci. 2000;319:25-37.
3. Forman DE, Butler J, Wang Y, Abraham WT, O'Connor CM, Gottlieb SS, Loh E, Massie BM, Rich MW, Stevenson LW, Young JB, Krumholz HM. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol. 2004;43:61-67.
4. Heywood JT. The cardiorenal syndrome: lessons from the ADHERE database and treatment options. Heart Fail Rev. 2004;9:195-201. doi: 10.1007/s10741-005-6129-4.
5. Canessa CM, Schild L, Buell G, Thorens B, Gautschi I, Horisberger JD, Rossier BC. Amiloride-sensitive epithelial Na+ channel is made of three homologous subunits. Nature. 1994;367:463-467. doi: 10.1038/367463a0.
6. Rossier BC, Canessa CM, Schild L, Horisberger JD. Epithelial sodium channels. Curr Opin Nephrol Hypertens. 1994;3:487-496.
7. Beutler KT, Masilamani S, Turban S, Nielsen J, Brooks HL, Ageloff S, Fenton RA, Packer RK, Knepper MA. Long-term regulation of ENaC expression in kidney by angiotensin II. Hypertension. 2003;41:1143-1150. doi: 10.1161/01.HYP.0000066129.12106.E2.
8. Ecelbarger CA, Kim GH, Terris J, Masilamani S, Mitchell C, Reyes I, Verbalis JG, Knepper MA. Vasopressin-mediated regulation of epithelial sodium channel abundance in rat kidney. Am J Physiol Renal Physiol. 2000;279:F46-F53.
9. Blazer-Yost BL, Liu X, Helman SI. Hormonal regulation of ENaCs: insulin and aldosterone. Am J Physiol. 1998;274(5 pt 1):C1373-C1379.
10. Briet M, Schiffrin EL. Aldosterone: effects on the kidney and cardiovascular system. Nat Rev Nephrol. 2010;6:261-273. doi: 10.1038/nrneph.2010.30.
11. Zheng H, Liu X, Rao US, Patel KP. Increased renal ENaC subunits and sodium retention in rats with chronic heart failure. Am J Physiol Renal Physiol. 2011;300:F641-F649. doi: 10.1152/ajprenal.00254.2010.
12. Hughey RP, Mueller GM, Bruns JB, Kinlough CL, Poland PA, Harkleroad KL, Carattino MD, Kleyman TR. Maturation of the epithelial Na+ channel involves proteolytic processing of the alpha- and gamma-subunits. J Biol Chem. 2003;278:37073-37082. doi: 10.1074/jbc.M307003200.
13. Hughey RP, Carattino MD, Kleyman TR. Role of proteolysis in the activation of epithelial sodium channels. Curr Opin Nephrol Hypertens. 2007;16:444-450. doi: 10.1097/MNH.0b013e32821f6072.
14. Passero CJ, Carattino MD, Kashlan OB, Myerburg MM, Hughey RP, Kleyman TR. Defining an inhibitory domain in the gamma subunit of the epithelial sodium channel. Am J Physiol Renal Physiol. 2010;299:F854-F861. doi: 10.1152/ajprenal.00316.2010.
15. Hamm LL, Feng Z, Hering-Smith KS. Regulation of sodium transport by ENaC in the kidney. Curr Opin Nephrol Hypertens. 2010;19:98-105. doi: 10.1097/MNH.0b013e328332bda4.
16. Passero CJ, Mueller GM, Rondon-Berrios H, Tofovic SP, Hughey RP, Kleyman TR. Plasmin activates epithelial Na+ channels by cleaving the gamma subunit. J Biol Chem. 2008;283:36586-36591. doi: 10.1074/jbc. M805676200.
17. Svenningsen P, Bistrup C, Friis UG, Bertog M, Haerteis S, Krueger B, Stubbe J, Jensen ON, Thiesson HC, Uhrenholt TR, Jespersen B, Jensen BL, Korbmacher C, Skøtt O. Plasmin in nephrotic urine activates the epithelial sodium channel. J Am Soc Nephrol. 2009;20:299-310. doi: 10.1681/ASN.2008040364.
18. Maekawa A, Kakizoe Y, Miyoshi T, Wakida N, Ko T, Shiraishi N, Adachi M, Tomita K, Kitamura K. Camostat mesilate inhibits prostasin activity and reduces blood pressure and renal injury in salt-sensitive hypertension. J Hypertens. 2009;27:181-189.
19. Ruffieux-Daidié D, Staub O. Intracellular ubiquitylation of the epithelial Na+ channel controls extracellular proteolytic channel activation via conformational change. J Biol Chem. 2011;286:2416-2424. doi: 10.1074/jbc. M110.176156.
20. Ruffieux-Daidié D, Poirot O, Boulkroun S, Verrey F, Kellenberger S, Staub O. Deubiquitylation regulates activation and proteolytic cleavage of ENaC. J Am Soc Nephrol. 2008;19:2170-2180. doi: 10.1681/ASN.2007101130.
21. Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA, Braunwald E. Myocardial infarct size and ventricular function in rats. Circ Res. 1979;44:503-512.
22. Fishbein MC, Maclean D, Maroko PR. Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution. Am J Pathol. 1978;90:57-70.
23. Xu DL, Martin PY, Ohara M, St John J, Pattison T, Meng X, Morris K, Kim JK, Schrier RW. Upregulation of aquaporin-2 water channel expression in chronic heart failure rat. J Clin Invest. 1997;99:1500-1505. doi: 10.1172/JCI119312.
24. Lütken SC, Kim SW, Jonassen T, Marples D, Knepper MA, Kwon TH, Frøkiaer J, Nielsen S. Changes of renal AQP2, ENaC, and NHE3 in experimentally induced heart failure: response to angiotensin II AT1 receptor blockade. Am J Physiol Renal Physiol. 2009;297:F1678-F1688. doi: 10.1152/ajprenal.00010.2009.
25. Yaoita E, Kawasaki K, Yamamoto T, Kihara I. Variable expression of desmin in rat glomerular epithelial cells. Am J Pathol. 1990;136:899-908.
26. Rossier BC, Stutts MJ. Activation of the epithelial sodium channel (ENaC) by serine proteases. Annu Rev Physiol. 2009;71:361-379. doi: 10.1146/annurev.physiol.010908.163108.
27. Kleyman TR, Carattino MD, Hughey RP. ENaC at the cutting edge: regulation of epithelial sodium channels by proteases. J Biol Chem. 2009;284:20447-20451. doi: 10.1074/jbc.R800083200.
28. Li K, Guo D, Zhu H, Hering-Smith KS, Hamm LL, Ouyang J, Dong Y. Interleukin-6 stimulates epithelial sodium channels in mouse cortical collecting duct cells. Am J Physiol Regul Integr Comp Physiol. 2010;299:R590-R595. doi: 10.1152/ajpregu.00207.2009.
29. Chalfant ML, Peterson-Yantorno K, O'Brien TG, Civan MM. Regulation of epithelial Na+ channels from M-1 cortical collecting duct cells. Am J Physiol. 1996;271(4 pt 2):F861-F870.
30. Vallet V, Chraibi A, Gaeggeler HP, Horisberger JD, Rossier BC. An epithelial serine protease activates the amiloride-sensitive sodium channel. Nature. 1997;389:607-610. doi: 10.1038/39329.
31. Passero CJ, Hughey RP, Kleyman TR. New role for plasmin in sodium homeostasis. Curr Opin Nephrol Hypertens. 2010;19:13-19. doi: 10.1097/MNH.0b013e3283330fb2.
32. Waxler B, Rabito SF. Aprotinin: a serine protease inhibitor with therapeutic actions: its interaction with ACE inhibitors. Curr Pharm Des. 2003;9:777-787.
33. Smith MS, Muir H, Hall R. Perioperative management of drug therapy, clinical considerations. Drugs. 1996;51:238-259.
34. Blé FX, Cannet C, Collingwood S, Danahay H, Beckmann N. ENaCmediated effects assessed by MRI in a rat model of hypertonic salineinduced lung hydration. Br J Pharmacol. 2010;160:1008-1015. doi: 10.1111/j.1476-5381.2010.00747.x.
35. + transport in response to apical fluid volume expansion in human H441 airway epithelial cells. Pflugers Arch. 2011;462:431-441. doi: 10.1007/s00424-011-0982-x.
36. Galizia L, Ojea A, Kotsias BA. [Amiloride sensitive sodium channels (ENaC) and their regulation by proteases]. Medicina (B Aires). 2011;71:179-182.
37. Molloy SS, Bresnahan PA, Leppla SH, Klimpel KR, Thomas G. Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen. J Biol Chem. 1992;267:16396-16402.
38. Uchimura K, Kakizoe Y, Onoue T, Hayata M, Morinaga J, Yamazoe R, Ueda M, Mizumoto T, Adachi M, Miyoshi T, Shiraishi N, Sakai Y, Tomita K, Kitamura K. In vivo contribution of serine proteases to the proteolytic activation of γENaC in aldosterone-infused rats. Am J Physiol Renal Physiol. 2012;303:F939-F943. doi: 10.1152/ajprenal.00705.2011.
39. Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B. The severe cardiorenal syndrome: 'Guyton revisited'. Eur Heart J. 2005;26:11-17. doi: 10.1093/eurheartj/ehi020.
40. Packer M. Neurohormonal interactions and adaptations in congestive heart failure. Circulation. 1988;77:721-730.
41. Patel KP, Zhang K, Carmines PK. Norepinephrine turnover in peripheral tissues of rats with heart failure. Am J Physiol Regul Integr Comp Physiol. 2000;278:R556-R562.
42. Packer M, Lee WH, Kessler PD, Gottlieb SS, Bernstein JL, Kukin ML. Role of neurohormonal mechanisms in determining survival in patients with severe chronic heart failure. Circulation. 1987;75:IV80-IV92.
43. Pedersen EB, Danielsen H, Jensen T, Madsen M, Sørensen SS, Thomsen OO. Angiotensin II, aldosterone and arginine vasopressin in plasma in congestive heart failure. Eur J Clin Invest. 1986;16:56-60.
44. Kleiber AC, Zheng H, Schultz HD, Peuler JD, Patel KP. Exercise training normalizes enhanced glutamate-mediated sympathetic activation from the PVN in heart failure. Am J Physiol Regul Integr Comp Physiol. 2008;294:R1863-R1872. doi: 10.1152/ajpregu.00757.2007.
45. Narikiyo T, Kitamura K, Adachi M, Miyoshi T, Iwashita K, Shiraishi N, Nonoguchi H, Chen LM, Chai KX, Chao J, Tomita K. Regulation of prostasin by aldosterone in the kidney. J Clin Invest. 2002;109:401-408. doi: 10.1172/JCI13229.
46. Rafiq K, Noma T, Fujisawa Y, Ishihara Y, Arai Y, Nabi AH, Suzuki F, Nagai Y, Nakano D, Hitomi H, Kitada K, Urushihara M, Kobori H, Kohno M, Nishiyama A. Renal sympathetic denervation suppresses de novo podocyte injury and albuminuria in rats with aortic regurgitation. Circulation. 2012;125:1402-1413. doi: 10.1161/CIRCULATIONAHA.111.064097.
47. Ellekilde G, Holm J, Hemmingsen L, Koczulab B, von Eyben FE. Impact of inhibition of angiotensin-converting enzyme on urinary excretion of proteins in chronic heart failure. Clin Chem. 1992;38:1377-1378.
48. Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJ, Yusuf S, Granger CB, Michelson EL, Ostergren J, Cornel JH, de Zeeuw D, Pocock S, van Veldhuisen DJ; Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Investigators. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation. 2006;113:671-678. doi: 10.1161/CIRCULATIONAHA.105.580506.